Remo CRO

News

FDA Pushes Proactive Clinical Trial Quality Control

03.16 2017.

Protocol violations and faulty record-keeping habits continue to be among the most common problems uncovered by U.S. Food and Drug Administration (FDA) inspectors, says David Burrow, PharmD, JD, acting director of the Office of Scientific Investigations within the Office of Compliance for the FDA’s Center for Drug Evaluation and Research. Burrow’s tip? Remember that “quality […] Details

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

03.16 2017.

LONDON, Feb. 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary… Details

Financial ties between researchers and drug industry linked to positive trial results

03.16 2017.

Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a… Details

BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease

03.16 2017.

MELVILLE, N.Y., February 8, 2017 – BioRestorative Therapies, Inc. (“BRT” or the “Company”) (BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has received clearance by the U.S. Food and Drug… Details

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published

03.16 2017.

CHARLOTTESVILLE, Va., Feb. 08, 2017 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other hypoxia-related… Details

New clinical trial shows 'promising results' for ASD treatment

03.16 2017.

Researchers from Arizona State University are developing autism treatments by improving the gut microbiota through fecal microbial transplants. Details